COURTNEY HODGE: Open Payments
NPI 1003503582 · LYNN HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,936 in 76 payments from 26 companies in 2025. Trend: 2023 $624 · 2024 $2,253 · 2025 $1,936
Food & beverage: $1,538Education: $398
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 8 | $243 |
| Astellas Pharma US Inc | 5 | $243 |
| E.R. Squibb & Sons, L.L.C. | 9 | $191 |
| Janssen Biotech, Inc. | 7 | $180 |
| Novartis Pharmaceuticals Corporation | 6 | $136 |
| Merck Sharp & Dohme LLC | 6 | $125 |
| GlaxoSmithKline, LLC. | 5 | $111 |
| Genentech USA, Inc. | 5 | $107 |
| Celgene Corporation | 3 | $72 |
| Pharmacosmos Therapeutics Inc. | 1 | $72 |
Products named: OPDIVO, DARZALEX, KEYTRUDA, JAKAFI, REBLOZYL, JEMPERLI, MONOFERRIC, Polivy.
Industry payments across FL — which companies pay providers there.
